James P. Tursi, M.D. is the Chief Medical Officer for Auxilium Pharmaceuticals, a specialty biopharmaceutical company based in Malvern, Pennsylvania. Auxilium specializes in the development and commercialization of products serving unmet medical needs.

Dr. Tursi received his doctor of medicine degree from the Medical College of Pennsylvania. He subsequently completed his residency training at the Johns Hopkins Hospital and entered clinical practice in Southern New Jersey caring for indigent patients. He practiced Medicine for over 10 years and created a medical education company, I Will Pass®, which assists physicians in the process of board certification.
He entered the pharmaceutical industry as a Medical Director for Procter and Gamble Pharmaceuticals. He worked on several products and therapeutic areas, which included female sexual dysfunction, overactive bladder, and osteoporosis. His responsibilities included Clinical Development and Medical Affairs. He moved to GSK Biologicals in 2006 and he directed all Medical Affairs responsibilities for cancer vaccines in North America.

In March of 2009, he assumed responsibility of the Clinical R&D organization at Auxilium. As CMO, he is currently responsible for oversight of Medical Affairs, Clinical Development, Clinical Operations, Biometrics, Nonclinical activities and Medical Writing. He leads a team of 50 individuals involved in activities across several indications.

He lives in Southern New Jersey with his wife Marla and son Nicholas.